Petros Pharmaceuticals Inc. (PTPI) NASDAQ
$0.68 0.03 (4.60%)
Market Cap: $4.47M
As of 04/23/24 04:00 PM EDT. Market closed.
Petros Pharmaceuticals Inc. (PTPI)
NASDAQ
$0.68
0.03 (4.60%)
Market Cap: $4.47M
As of 04/23/24 04:00 PM EDT. Market closed.
Add to Portfolio
at petros, we are bringing new approaches to the most challenging conditions in men's health. we seek to understand the various health phases throughout a man’s journey. we collaborate with researchers, scientists, medical thought leaders and payers to ensure our therapies aid in restoring men’s body function to ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
1801 26th St, California, Sacramento, 95816-7301.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
1
URL
Address
1801 26th St, California, Sacramento, 95816-7301.
PRICE CHART FOR PETROS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.67
Previous Close
$0.65
Days Range
$0.64 - $0.71
52 week range
$0.63 - $6.35
Volume
615,206
Avg. Volume (30 days)
610,387
Market Cap
$4.47M
Dividend Yield
-
P/E
(0.32)
Shares Outstanding
6,875,814
Open
$0.67
Previous Close
$0.65
Days Range
$0.64 - $0.71
52 week range
$0.63 - $6.35
Volume
615,206
Avg. Volume (30 days)
610,387
Market Cap
$4.47M
Dividend Yield
-
P/E
(0.32)
Shares Outstanding
6,875,814
FINANCIAL STATEMENTS FOR PETROS PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR PETROS PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
SHULMAN JOHN D | Director | Dec 22, 2021 | Buy | $3.43 | 145,773 | 500,001 | 5,703,544 | Jan 03, 2022, 06:13 AM |
SHULMAN JOHN D | Director | Nov 29, 2021 | Buy | $3.00 | 500,000 | 1,500,000 | 5,557,771 | Nov 30, 2021, 02:49 PM |
SHULMAN JOHN D | Director | Oct 18, 2021 | Buy | $1.72 | 1,661,807 | 2,849,999 | 5,057,771 | Oct 21, 2021, 08:47 AM |
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
SHULMAN JOHN D | Director | 12/22/2021 | 500,001 |
SHULMAN JOHN D | Director | 11/29/2021 | 1,500,000 |
SHULMAN JOHN D | Director | 10/18/2021 | 2,849,999 |
FUNDS WITH A POSITION IN PETROS PHARMACEUTICALS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 16,594 | 0% | 0.51% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 10,502 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR PETROS PHARMACEUTICALS INC
STOCK BUYBACKS FOR PETROS PHARMACEUTICALS INC
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0.10%
1Q
03/31/2023
1.48%
2Q
12/31/2022
2.17%
3Q
09/30/2022
2.47%
4Q
06/30/2022
2.47%
5Q
03/31/2022
2.47%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PETROS PHARMACEUTICALS INC
LOADING...